Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.66637585 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.35689498 |
3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.35689498 |
4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.14861203 |
5 | regulation of vitamin metabolic process (GO:0030656) | 3.85166239 |
6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.62720093 |
7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.62720093 |
8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.62720093 |
9 | modulation by symbiont of host immune response (GO:0052553) | 3.62720093 |
10 | positive regulation by symbiont of host defense response (GO:0052509) | 3.62720093 |
11 | modulation by symbiont of host defense response (GO:0052031) | 3.62720093 |
12 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.58063573 |
13 | germinal center formation (GO:0002467) | 3.54304561 |
14 | regulation of podosome assembly (GO:0071801) | 3.53969477 |
15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.49730088 |
16 | T-helper 1 type immune response (GO:0042088) | 3.49509895 |
17 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.48068241 |
18 | * regulation of interferon-beta biosynthetic process (GO:0045357) | 3.41057209 |
19 | myeloid dendritic cell differentiation (GO:0043011) | 3.39109613 |
20 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.30086180 |
21 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.27501436 |
22 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.23401491 |
23 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.22798064 |
24 | response to protozoan (GO:0001562) | 3.17390956 |
25 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.16240403 |
26 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.16190598 |
27 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.14002855 |
28 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.10186263 |
29 | positive regulation of interferon-alpha production (GO:0032727) | 3.08779428 |
30 | detection of other organism (GO:0098543) | 3.08638473 |
31 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.06561819 |
32 | positive regulation of type 2 immune response (GO:0002830) | 3.04314722 |
33 | activation of MAPKKK activity (GO:0000185) | 3.03979433 |
34 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.03957588 |
35 | regulation of chronic inflammatory response (GO:0002676) | 3.02805467 |
36 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.01868743 |
37 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.01627511 |
38 | negative regulation of cell killing (GO:0031342) | 3.00827755 |
39 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.00827755 |
40 | detection of bacterium (GO:0016045) | 3.00667792 |
41 | regulation of interferon-alpha production (GO:0032647) | 2.92721126 |
42 | regulation of cholesterol storage (GO:0010885) | 2.92478495 |
43 | low-density lipoprotein particle clearance (GO:0034383) | 2.90560707 |
44 | regulation of cholesterol homeostasis (GO:2000188) | 2.90544132 |
45 | positive regulation of heat generation (GO:0031652) | 2.90333244 |
46 | myeloid dendritic cell activation (GO:0001773) | 2.89963661 |
47 | regulation of type 2 immune response (GO:0002828) | 2.88732945 |
48 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.88079322 |
49 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.87441865 |
50 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.83886028 |
51 | intestinal cholesterol absorption (GO:0030299) | 2.83139742 |
52 | cellular response to zinc ion (GO:0071294) | 2.80822037 |
53 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.75525545 |
54 | * regulation of chemokine biosynthetic process (GO:0045073) | 2.74978800 |
55 | positive regulation of B cell differentiation (GO:0045579) | 2.74853261 |
56 | protein localization to endosome (GO:0036010) | 2.74293422 |
57 | kynurenine metabolic process (GO:0070189) | 2.73971483 |
58 | phospholipid efflux (GO:0033700) | 2.73714534 |
59 | * positive regulation of chemokine biosynthetic process (GO:0045080) | 2.73360248 |
60 | regulation of fever generation (GO:0031620) | 2.72380188 |
61 | plasma lipoprotein particle clearance (GO:0034381) | 2.72360404 |
62 | granulocyte activation (GO:0036230) | 2.71856175 |
63 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.71181312 |
64 | glycosphingolipid catabolic process (GO:0046479) | 2.71000268 |
65 | alpha-linolenic acid metabolic process (GO:0036109) | 2.69596336 |
66 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.69218678 |
67 | detection of external biotic stimulus (GO:0098581) | 2.69075239 |
68 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.68704297 |
69 | protein carboxylation (GO:0018214) | 2.68704297 |
70 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.65863368 |
71 | neutrophil activation involved in immune response (GO:0002283) | 2.64721285 |
72 | * macrophage activation involved in immune response (GO:0002281) | 2.64493055 |
73 | dendritic cell differentiation (GO:0097028) | 2.64260960 |
74 | tryptophan catabolic process (GO:0006569) | 2.64010849 |
75 | indole-containing compound catabolic process (GO:0042436) | 2.64010849 |
76 | indolalkylamine catabolic process (GO:0046218) | 2.64010849 |
77 | regulation of antigen processing and presentation (GO:0002577) | 2.63995352 |
78 | regulation of triglyceride catabolic process (GO:0010896) | 2.63705288 |
79 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.63618901 |
80 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.62962403 |
81 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.62860938 |
82 | response to host (GO:0075136) | 2.62860938 |
83 | response to host defenses (GO:0052200) | 2.62860938 |
84 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.62695583 |
85 | B cell mediated immunity (GO:0019724) | 2.61638371 |
86 | * cellular response to lipopolysaccharide (GO:0071222) | 2.61350541 |
87 | immunoglobulin mediated immune response (GO:0016064) | 2.59900901 |
88 | response to peptidoglycan (GO:0032494) | 2.58150073 |
89 | protein-lipid complex assembly (GO:0065005) | 2.58043216 |
90 | urea cycle (GO:0000050) | 2.57666026 |
91 | urea metabolic process (GO:0019627) | 2.57666026 |
92 | cellular response to interferon-gamma (GO:0071346) | 2.57570373 |
93 | regulation of gamma-delta T cell activation (GO:0046643) | 2.57345186 |
94 | regulation of mononuclear cell migration (GO:0071675) | 2.57187655 |
95 | valine metabolic process (GO:0006573) | 2.56779190 |
96 | negative regulation of cholesterol transport (GO:0032375) | 2.56385176 |
97 | negative regulation of sterol transport (GO:0032372) | 2.56385176 |
98 | phospholipid homeostasis (GO:0055091) | 2.56277702 |
99 | plasma lipoprotein particle assembly (GO:0034377) | 2.55775463 |
100 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.55737133 |
101 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.55439789 |
102 | tryptophan metabolic process (GO:0006568) | 2.55185410 |
103 | * cellular response to molecule of bacterial origin (GO:0071219) | 2.54016954 |
104 | regulation of interleukin-12 production (GO:0032655) | 2.53822486 |
105 | modulation by symbiont of host cellular process (GO:0044068) | 2.53760568 |
106 | virion attachment to host cell (GO:0019062) | 2.53352666 |
107 | adhesion of symbiont to host cell (GO:0044650) | 2.53352666 |
108 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.51643407 |
109 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.51307533 |
110 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.49440659 |
111 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.49222417 |
112 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.48695192 |
113 | high-density lipoprotein particle remodeling (GO:0034375) | 2.47884776 |
114 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.47736930 |
115 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.47260338 |
116 | mannose metabolic process (GO:0006013) | 2.46761318 |
117 | detection of biotic stimulus (GO:0009595) | 2.46645967 |
118 | apoptotic cell clearance (GO:0043277) | 2.45804854 |
119 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.45580993 |
120 | positive regulation of antigen processing and presentation (GO:0002579) | 2.45135993 |
121 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.45022846 |
122 | respiratory burst (GO:0045730) | 2.44853871 |
123 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.44789507 |
124 | reverse cholesterol transport (GO:0043691) | 2.44116832 |
125 | glycolipid catabolic process (GO:0019377) | 2.43871122 |
126 | aromatic amino acid family catabolic process (GO:0009074) | 2.42908295 |
127 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.41705578 |
128 | sulfur amino acid catabolic process (GO:0000098) | 2.39645607 |
129 | lipoprotein metabolic process (GO:0042157) | 2.38085210 |
130 | pinocytosis (GO:0006907) | 2.37041687 |
131 | regulation of cholesterol esterification (GO:0010872) | 2.36336968 |
132 | intestinal absorption (GO:0050892) | 2.35692028 |
133 | response to type I interferon (GO:0034340) | 2.35131604 |
134 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.34366269 |
135 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.34366269 |
136 | lysine metabolic process (GO:0006553) | 2.32694231 |
137 | lysine catabolic process (GO:0006554) | 2.32694231 |
138 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.32379625 |
139 | defense response to protozoan (GO:0042832) | 2.32375875 |
140 | * lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.31843793 |
141 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.30215662 |
142 | negative regulation of fibrinolysis (GO:0051918) | 2.30215423 |
143 | type I interferon signaling pathway (GO:0060337) | 2.29772804 |
144 | cellular response to type I interferon (GO:0071357) | 2.29772804 |
145 | protein-lipid complex remodeling (GO:0034368) | 2.29539824 |
146 | macromolecular complex remodeling (GO:0034367) | 2.29539824 |
147 | plasma lipoprotein particle remodeling (GO:0034369) | 2.29539824 |
148 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.28914891 |
149 | negative regulation of interleukin-12 production (GO:0032695) | 2.28052091 |
150 | response to muramyl dipeptide (GO:0032495) | 2.27625890 |
151 | positive regulation of lipid storage (GO:0010884) | 2.27467652 |
152 | COPI coating of Golgi vesicle (GO:0048205) | 2.27056703 |
153 | Golgi transport vesicle coating (GO:0048200) | 2.27056703 |
154 | nitrogen cycle metabolic process (GO:0071941) | 2.27036740 |
155 | NIK/NF-kappaB signaling (GO:0038061) | 2.26963146 |
156 | homocysteine metabolic process (GO:0050667) | 2.26269300 |
157 | detection of molecule of bacterial origin (GO:0032490) | 2.26215928 |
158 | mature B cell differentiation involved in immune response (GO:0002313) | 2.25203704 |
159 | mature B cell differentiation (GO:0002335) | 2.25122650 |
160 | I-kappaB phosphorylation (GO:0007252) | 2.24364345 |
161 | positive regulation of lipid catabolic process (GO:0050996) | 2.23970326 |
162 | response to host immune response (GO:0052572) | 2.23930002 |
163 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.23930002 |
164 | reactive oxygen species biosynthetic process (GO:1903409) | 2.23920372 |
165 | tricarboxylic acid metabolic process (GO:0072350) | 2.23227695 |
166 | regulation of B cell differentiation (GO:0045577) | 2.22739345 |
167 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.22255028 |
168 | 2-oxoglutarate metabolic process (GO:0006103) | 2.21002655 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.41514893 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.27715639 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.40877016 |
4 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.14735472 |
5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.07138224 |
6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.02038576 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.85041285 |
8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.57047991 |
9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.53341455 |
10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.49355755 |
11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.42209536 |
12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.42136351 |
13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.39697904 |
14 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.39392159 |
15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.37528370 |
16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.36404709 |
17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.35043678 |
18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.34438280 |
19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.28578893 |
20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.26678508 |
21 | MYC_22102868_ChIP-Seq_BL_Human | 2.12932916 |
22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.08899615 |
23 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.08624289 |
24 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.07818338 |
25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.96404389 |
26 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.90206497 |
27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.80603931 |
28 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.79682023 |
29 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.78745445 |
30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.77481873 |
31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76618823 |
32 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.74967908 |
33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.74642999 |
34 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.72986444 |
35 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.70767479 |
36 | MAF_26560356_Chip-Seq_TH1_Human | 1.70082442 |
37 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.69174200 |
38 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.66864594 |
39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.64315843 |
40 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.64122039 |
41 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.62835748 |
42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.61003695 |
43 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.59721083 |
44 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.57622988 |
45 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.56490302 |
46 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.55952886 |
47 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.52861480 |
48 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.51745722 |
49 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.51286761 |
50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.46950116 |
51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.45527199 |
52 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.45327763 |
53 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.45088554 |
54 | MYB_26560356_Chip-Seq_TH2_Human | 1.42618477 |
55 | UTX_26944678_Chip-Seq_JUKART_Human | 1.42380687 |
56 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.37891042 |
57 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36951908 |
58 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.36496808 |
59 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.36215312 |
60 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.36131576 |
61 | MYB_26560356_Chip-Seq_TH1_Human | 1.34109699 |
62 | SPI1_23127762_ChIP-Seq_K562_Human | 1.30949267 |
63 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.29712642 |
64 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.29202110 |
65 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28617031 |
66 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27872745 |
67 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.27773482 |
68 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.26757041 |
69 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.26696111 |
70 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24342859 |
71 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.24224723 |
72 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.20440099 |
73 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.19900343 |
74 | KDM2B_26808549_Chip-Seq_K562_Human | 1.19598732 |
75 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.19406264 |
76 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.17820787 |
77 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.17769894 |
78 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16985616 |
79 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15408703 |
80 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.15174214 |
81 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14779646 |
82 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.12905346 |
83 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12562221 |
84 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11953846 |
85 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11404228 |
86 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10967615 |
87 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10563185 |
88 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.10388820 |
89 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.10110908 |
90 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09402067 |
91 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.09281398 |
92 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09054767 |
93 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.08921444 |
94 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08900121 |
95 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.08775298 |
96 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.08732699 |
97 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08395891 |
98 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08243067 |
99 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08144314 |
100 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.07610845 |
101 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.07583376 |
102 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.05853580 |
103 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.05131263 |
104 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04789044 |
105 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.04629618 |
106 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02406170 |
107 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02291007 |
108 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01886325 |
109 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00761425 |
110 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00667187 |
111 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00136408 |
112 | MAF_26560356_Chip-Seq_TH2_Human | 0.99782310 |
113 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.98819014 |
114 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.98534260 |
115 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.98521183 |
116 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.98227096 |
117 | ATF3_27146783_Chip-Seq_COLON_Human | 0.97576155 |
118 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.95932199 |
119 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.95594160 |
120 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94398261 |
121 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.93572122 |
122 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.93231989 |
123 | GATA2_19941826_ChIP-Seq_K562_Human | 0.93122770 |
124 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.92208919 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 3.54867023 |
2 | MP0009840_abnormal_foam_cell | 2.86998181 |
3 | MP0002139_abnormal_hepatobiliary_system | 2.84807511 |
4 | MP0001835_abnormal_antigen_presentation | 2.71793039 |
5 | MP0003436_decreased_susceptibility_to | 2.49908628 |
6 | MP0003303_peritoneal_inflammation | 2.48521203 |
7 | MP0005365_abnormal_bile_salt | 2.42293843 |
8 | MP0005058_abnormal_lysosome_morphology | 2.29109838 |
9 | MP0003300_gastrointestinal_ulcer | 2.18037355 |
10 | MP0003191_abnormal_cellular_cholesterol | 2.17454305 |
11 | MP0009785_altered_susceptibility_to | 2.00234810 |
12 | MP0005085_abnormal_gallbladder_physiolo | 1.95226803 |
13 | MP0003705_abnormal_hypodermis_morpholog | 1.93971110 |
14 | MP0001666_abnormal_nutrient_absorption | 1.88874862 |
15 | MP0005387_immune_system_phenotype | 1.87729813 |
16 | MP0001790_abnormal_immune_system | 1.87729813 |
17 | * MP0002419_abnormal_innate_immunity | 1.87047830 |
18 | * MP0005025_abnormal_response_to | 1.80927395 |
19 | MP0003252_abnormal_bile_duct | 1.80303538 |
20 | MP0000685_abnormal_immune_system | 1.80097992 |
21 | MP0005000_abnormal_immune_tolerance | 1.72537440 |
22 | * MP0001800_abnormal_humoral_immune | 1.72019630 |
23 | MP0005464_abnormal_platelet_physiology | 1.71978726 |
24 | MP0008004_abnormal_stomach_pH | 1.67659488 |
25 | * MP0002452_abnormal_antigen_presenting | 1.66962603 |
26 | MP0008875_abnormal_xenobiotic_pharmacok | 1.65137889 |
27 | MP0004510_myositis | 1.60347425 |
28 | MP0006082_CNS_inflammation | 1.59920574 |
29 | MP0002148_abnormal_hypersensitivity_rea | 1.58696137 |
30 | MP0003724_increased_susceptibility_to | 1.55490404 |
31 | MP0002166_altered_tumor_susceptibility | 1.54223747 |
32 | MP0010329_abnormal_lipoprotein_level | 1.53633568 |
33 | * MP0002723_abnormal_immune_serum | 1.52818092 |
34 | MP0004947_skin_inflammation | 1.51698325 |
35 | MP0010155_abnormal_intestine_physiology | 1.49803967 |
36 | MP0010352_gastrointestinal_tract_polyps | 1.49281879 |
37 | MP0005671_abnormal_response_to | 1.45647810 |
38 | MP0001853_heart_inflammation | 1.45341947 |
39 | * MP0001845_abnormal_inflammatory_respons | 1.43982629 |
40 | MP0003566_abnormal_cell_adhesion | 1.43521415 |
41 | MP0001533_abnormal_skeleton_physiology | 1.41498402 |
42 | MP0000609_abnormal_liver_physiology | 1.40276676 |
43 | MP0002138_abnormal_hepatobiliary_system | 1.39439443 |
44 | * MP0008469_abnormal_protein_level | 1.39059118 |
45 | * MP0001819_abnormal_immune_cell | 1.39050721 |
46 | * MP0002420_abnormal_adaptive_immunity | 1.37894224 |
47 | MP0005083_abnormal_biliary_tract | 1.36249042 |
48 | MP0003172_abnormal_lysosome_physiology | 1.35715862 |
49 | MP0003763_abnormal_thymus_physiology | 1.34603708 |
50 | MP0003091_abnormal_cell_migration | 1.34386378 |
51 | MP0003828_pulmonary_edema | 1.29179306 |
52 | MP0001873_stomach_inflammation | 1.26356196 |
53 | * MP0005166_decreased_susceptibility_to | 1.25085067 |
54 | MP0002405_respiratory_system_inflammati | 1.25053223 |
55 | MP0008260_abnormal_autophagy | 1.24461452 |
56 | MP0009643_abnormal_urine_homeostasis | 1.23283612 |
57 | MP0002332_abnormal_exercise_endurance | 1.22334247 |
58 | MP0009764_decreased_sensitivity_to | 1.21940209 |
59 | * MP0009333_abnormal_splenocyte_physiolog | 1.21146967 |
60 | MP0005332_abnormal_amino_acid | 1.19327066 |
61 | MP0005319_abnormal_enzyme/_coenzyme | 1.17850805 |
62 | MP0010234_abnormal_vibrissa_follicle | 1.15397392 |
63 | MP0002006_tumorigenesis | 1.15157277 |
64 | MP0005023_abnormal_wound_healing | 1.14271846 |
65 | * MP0000716_abnormal_immune_system | 1.13018890 |
66 | MP0003806_abnormal_nucleotide_metabolis | 1.12397818 |
67 | MP0000343_altered_response_to | 1.12264488 |
68 | MP0002398_abnormal_bone_marrow | 1.11011053 |
69 | MP0003656_abnormal_erythrocyte_physiolo | 1.09918631 |
70 | MP0009278_abnormal_bone_marrow | 1.07891464 |
71 | MP0003866_abnormal_defecation | 1.07631214 |
72 | MP0005076_abnormal_cell_differentiation | 1.06356748 |
73 | MP0000689_abnormal_spleen_morphology | 1.05684431 |
74 | MP0005397_hematopoietic_system_phenotyp | 1.05650555 |
75 | MP0001545_abnormal_hematopoietic_system | 1.05650555 |
76 | MP0000858_altered_metastatic_potential | 1.02648447 |
77 | MP0005164_abnormal_response_to | 1.02584163 |
78 | MP0003186_abnormal_redox_activity | 1.01494787 |
79 | MP0005390_skeleton_phenotype | 1.00989156 |
80 | MP0000598_abnormal_liver_morphology | 1.00934328 |
81 | * MP0002429_abnormal_blood_cell | 0.99470799 |
82 | MP0002722_abnormal_immune_system | 0.99401552 |
83 | MP0008438_abnormal_cutaneous_collagen | 0.97187439 |
84 | MP0003183_abnormal_peptide_metabolism | 0.96175940 |
85 | MP0002118_abnormal_lipid_homeostasis | 0.96097447 |
86 | MP0010307_abnormal_tumor_latency | 0.94743435 |
87 | MP0002796_impaired_skin_barrier | 0.93697320 |
88 | MP0002396_abnormal_hematopoietic_system | 0.92252529 |
89 | MP0002877_abnormal_melanocyte_morpholog | 0.92190643 |
90 | MP0002136_abnormal_kidney_physiology | 0.91943487 |
91 | MP0005310_abnormal_salivary_gland | 0.91301413 |
92 | MP0000604_amyloidosis | 0.91236009 |
93 | MP0002254_reproductive_system_inflammat | 0.91223736 |
94 | MP0003195_calcinosis | 0.90028020 |
95 | MP0009763_increased_sensitivity_to | 0.89410994 |
96 | MP0005451_abnormal_body_composition | 0.89359660 |
97 | MP0002933_joint_inflammation | 0.89257583 |
98 | MP0001851_eye_inflammation | 0.89178498 |
99 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.88350250 |
100 | MP0001216_abnormal_epidermal_layer | 0.88337130 |
101 | MP0000490_abnormal_crypts_of | 0.88123828 |
102 | MP0006054_spinal_hemorrhage | 0.87811602 |
103 | MP0002998_abnormal_bone_remodeling | 0.85120431 |
104 | MP0000249_abnormal_blood_vessel | 0.84959251 |
105 | MP0003075_altered_response_to | 0.84889224 |
106 | MP0005165_increased_susceptibility_to | 0.84476195 |
107 | MP0004808_abnormal_hematopoietic_stem | 0.84256229 |
108 | * MP0003448_altered_tumor_morphology | 0.83560498 |
109 | MP0004264_abnormal_extraembryonic_tissu | 0.82852079 |
110 | MP0001542_abnormal_bone_strength | 0.82620239 |
111 | MP0003279_aneurysm | 0.81579154 |
112 | MP0003690_abnormal_glial_cell | 0.80960064 |
113 | MP0000767_abnormal_smooth_muscle | 0.80733267 |
114 | MP0001849_ear_inflammation | 0.79950781 |
115 | MP0005167_abnormal_blood-brain_barrier | 0.79915305 |
116 | MP0000465_gastrointestinal_hemorrhage | 0.79758197 |
117 | MP0001663_abnormal_digestive_system | 0.79594960 |
118 | MP0003453_abnormal_keratinocyte_physiol | 0.78645028 |
119 | MP0004019_abnormal_vitamin_homeostasis | 0.77733211 |
120 | MP0003045_fibrosis | 0.73646315 |
121 | MP0003795_abnormal_bone_structure | 0.72535806 |
122 | MP0008874_decreased_physiological_sensi | 0.71584414 |
123 | MP0005666_abnormal_adipose_tissue | 0.71376113 |
124 | MP0000678_abnormal_parathyroid_gland | 0.68990193 |
125 | MP0004883_abnormal_blood_vessel | 0.65871116 |
126 | MP0005257_abnormal_intraocular_pressure | 0.62523763 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of glycolipid metabolism (HP:0010969) | 4.97694682 |
2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.97694682 |
3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.97694682 |
4 | Eczematoid dermatitis (HP:0000976) | 3.87591027 |
5 | Recurrent abscess formation (HP:0002722) | 3.61217933 |
6 | Recurrent bacterial skin infections (HP:0005406) | 3.54899288 |
7 | Loss of speech (HP:0002371) | 3.49829835 |
8 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.45628457 |
9 | Optic neuritis (HP:0100653) | 3.44234221 |
10 | Retrobulbar optic neuritis (HP:0100654) | 3.44234221 |
11 | Autoimmune thrombocytopenia (HP:0001973) | 3.41390181 |
12 | Myocardial infarction (HP:0001658) | 3.22650945 |
13 | Stomatitis (HP:0010280) | 3.10021603 |
14 | Vacuolated lymphocytes (HP:0001922) | 3.04704316 |
15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.01137688 |
16 | Xanthomatosis (HP:0000991) | 2.97738994 |
17 | Abnormality of macrophages (HP:0004311) | 2.96948178 |
18 | Systemic lupus erythematosus (HP:0002725) | 2.95674070 |
19 | Increased IgE level (HP:0003212) | 2.89923368 |
20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.79134905 |
21 | Recurrent fungal infections (HP:0002841) | 2.78992644 |
22 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.76003464 |
23 | Mucopolysacchariduria (HP:0008155) | 2.76003464 |
24 | Hypoglycemic coma (HP:0001325) | 2.75574662 |
25 | Nuclear cataract (HP:0100018) | 2.75481227 |
26 | Recurrent skin infections (HP:0001581) | 2.71339764 |
27 | Deep venous thrombosis (HP:0002625) | 2.71094237 |
28 | Myositis (HP:0100614) | 2.69803350 |
29 | Increased cerebral lipofuscin (HP:0011813) | 2.67778698 |
30 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.65837982 |
31 | Pustule (HP:0200039) | 2.64447821 |
32 | * Recurrent viral infections (HP:0004429) | 2.63698254 |
33 | Axonal loss (HP:0003447) | 2.57949170 |
34 | Gastrointestinal stroma tumor (HP:0100723) | 2.56723604 |
35 | Hydroxyprolinuria (HP:0003080) | 2.56137495 |
36 | Abnormality of proline metabolism (HP:0010907) | 2.56137495 |
37 | Colitis (HP:0002583) | 2.54701133 |
38 | Dysostosis multiplex (HP:0000943) | 2.54135152 |
39 | Interstitial pulmonary disease (HP:0006530) | 2.52082709 |
40 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.51550795 |
41 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.51550795 |
42 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.51550795 |
43 | Keratoconjunctivitis sicca (HP:0001097) | 2.50502366 |
44 | Abnormality of the common coagulation pathway (HP:0010990) | 2.48510885 |
45 | Amyloidosis (HP:0011034) | 2.46651200 |
46 | Cellulitis (HP:0100658) | 2.44795183 |
47 | Gingival bleeding (HP:0000225) | 2.43296960 |
48 | Obstructive lung disease (HP:0006536) | 2.42987358 |
49 | Chronic obstructive pulmonary disease (HP:0006510) | 2.42987358 |
50 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.40863700 |
51 | Pulmonary infiltrates (HP:0002113) | 2.40402115 |
52 | Nausea (HP:0002018) | 2.36290460 |
53 | Malnutrition (HP:0004395) | 2.35886856 |
54 | Disinhibition (HP:0000734) | 2.34514124 |
55 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.33295362 |
56 | Generalized aminoaciduria (HP:0002909) | 2.33064431 |
57 | Thrombocytosis (HP:0001894) | 2.29891459 |
58 | Purpura (HP:0000979) | 2.28255013 |
59 | Emphysema (HP:0002097) | 2.27958861 |
60 | Thin bony cortex (HP:0002753) | 2.27898553 |
61 | Gingivitis (HP:0000230) | 2.25513495 |
62 | Neurofibrillary tangles (HP:0002185) | 2.24637451 |
63 | Complement deficiency (HP:0004431) | 2.24565038 |
64 | Hypobetalipoproteinemia (HP:0003563) | 2.24007161 |
65 | Abnormality of purine metabolism (HP:0004352) | 2.23009021 |
66 | Arterial thrombosis (HP:0004420) | 2.21212461 |
67 | Orchitis (HP:0100796) | 2.21079517 |
68 | Intrahepatic cholestasis (HP:0001406) | 2.20524985 |
69 | Keratoconjunctivitis (HP:0001096) | 2.19869568 |
70 | Periodontitis (HP:0000704) | 2.19864019 |
71 | Progressive neurologic deterioration (HP:0002344) | 2.18724569 |
72 | Joint hemorrhage (HP:0005261) | 2.18215017 |
73 | Impaired platelet aggregation (HP:0003540) | 2.17737780 |
74 | Abnormal platelet function (HP:0011869) | 2.17737780 |
75 | Increased IgM level (HP:0003496) | 2.17570185 |
76 | Polycythemia (HP:0001901) | 2.14733873 |
77 | Chronic otitis media (HP:0000389) | 2.14289280 |
78 | Gangrene (HP:0100758) | 2.13024702 |
79 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.10964926 |
80 | Recurrent cutaneous fungal infections (HP:0011370) | 2.10964926 |
81 | Cervical subluxation (HP:0003308) | 2.10801127 |
82 | Inflammation of the large intestine (HP:0002037) | 2.10582683 |
83 | Hypergammaglobulinemia (HP:0010702) | 2.10408703 |
84 | Peritonitis (HP:0002586) | 2.10383401 |
85 | Petechiae (HP:0000967) | 2.09223880 |
86 | Hypertensive crisis (HP:0100735) | 2.08502990 |
87 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.07595134 |
88 | Hyperammonemia (HP:0001987) | 2.06326707 |
89 | Abnormality of complement system (HP:0005339) | 2.06206329 |
90 | Glomerulonephritis (HP:0000099) | 2.06155159 |
91 | Esophageal varix (HP:0002040) | 2.05876853 |
92 | Gastrointestinal inflammation (HP:0004386) | 2.05510475 |
93 | Neuronal loss in central nervous system (HP:0002529) | 2.03150527 |
94 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.02836073 |
95 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.02581444 |
96 | Menorrhagia (HP:0000132) | 2.02118137 |
97 | Vasculitis (HP:0002633) | 2.01003812 |
98 | Increased serum ferritin (HP:0003281) | 2.00912964 |
99 | Vertebral compression fractures (HP:0002953) | 2.00711259 |
100 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.99091193 |
101 | Urticaria (HP:0001025) | 1.98857589 |
102 | Parakeratosis (HP:0001036) | 1.98786486 |
103 | Abnormality of nucleobase metabolism (HP:0010932) | 1.98746268 |
104 | Spondylolisthesis (HP:0003302) | 1.98701162 |
105 | Asymmetric septal hypertrophy (HP:0001670) | 1.96391742 |
106 | Epistaxis (HP:0000421) | 1.95584895 |
107 | Hemoptysis (HP:0002105) | 1.95195720 |
108 | Nasal polyposis (HP:0100582) | 1.95119878 |
109 | Mediastinal lymphadenopathy (HP:0100721) | 1.95029708 |
110 | Abnormality of iron homeostasis (HP:0011031) | 1.94834451 |
111 | Hepatosplenomegaly (HP:0001433) | 1.94787903 |
112 | Agammaglobulinemia (HP:0004432) | 1.94124421 |
113 | Ketosis (HP:0001946) | 1.94041066 |
114 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.93484292 |
115 | Abnormality of the nasal mucosa (HP:0000433) | 1.92715515 |
116 | Apathy (HP:0000741) | 1.92508075 |
117 | Hyperglycinuria (HP:0003108) | 1.92393746 |
118 | Mutism (HP:0002300) | 1.92188233 |
119 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.91385726 |
120 | Polygenic inheritance (HP:0010982) | 1.91309533 |
121 | Abnormal platelet volume (HP:0011876) | 1.90740453 |
122 | Hypolipoproteinemia (HP:0010981) | 1.90387390 |
123 | Restrictive lung disease (HP:0002091) | 1.90203398 |
124 | Prolonged neonatal jaundice (HP:0006579) | 1.90018173 |
125 | Prolonged partial thromboplastin time (HP:0003645) | 1.89046423 |
126 | Gastrointestinal infarctions (HP:0005244) | 1.89045702 |
127 | Diminished motivation (HP:0000745) | 1.88444613 |
128 | Abnormality of T cell physiology (HP:0011840) | 1.87013251 |
129 | Increased mean platelet volume (HP:0011877) | 1.86712833 |
130 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.85639789 |
131 | Bone pain (HP:0002653) | 1.84982966 |
132 | Achilles tendon contracture (HP:0001771) | 1.83424422 |
133 | Osteomyelitis (HP:0002754) | 1.83348539 |
134 | Abnormality of the intrinsic pathway (HP:0010989) | 1.83193469 |
135 | Acne (HP:0001061) | 1.82928475 |
136 | Meningitis (HP:0001287) | 1.82210231 |
137 | Fat malabsorption (HP:0002630) | 1.81052550 |
138 | Osteolytic defects of the hand bones (HP:0009699) | 1.80180705 |
139 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.80180705 |
140 | Encephalitis (HP:0002383) | 1.80123421 |
141 | Hyperlipoproteinemia (HP:0010980) | 1.79942621 |
142 | Mitral stenosis (HP:0001718) | 1.79896358 |
143 | Right ventricular cardiomyopathy (HP:0011663) | 1.79826007 |
144 | Hypoalphalipoproteinemia (HP:0003233) | 1.79443675 |
145 | Distal lower limb muscle weakness (HP:0009053) | 1.79345830 |
146 | Nephritis (HP:0000123) | 1.78703952 |
147 | Hyperparathyroidism (HP:0000843) | 1.78178028 |
148 | Cerebral inclusion bodies (HP:0100314) | 1.78039918 |
149 | Hematochezia (HP:0002573) | 1.76601361 |
150 | Upper motor neuron abnormality (HP:0002127) | 1.74850437 |
151 | Arthralgia (HP:0002829) | 1.74545919 |
152 | Thick nail (HP:0001805) | 1.74070375 |
153 | Spontaneous hematomas (HP:0007420) | 1.73991829 |
154 | Hemorrhage of the eye (HP:0011885) | 1.70336711 |
155 | Thoracic kyphosis (HP:0002942) | 1.69746091 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 4.72799932 |
2 | PRPF4B | 3.30067833 |
3 | TRIB3 | 3.15323722 |
4 | MAP4K1 | 3.15258100 |
5 | TAOK3 | 2.90997158 |
6 | PKN2 | 2.54404540 |
7 | TYK2 | 2.39432371 |
8 | TBK1 | 2.36775153 |
9 | IRAK3 | 2.31206453 |
10 | MAP3K10 | 2.11596286 |
11 | BLK | 1.96617058 |
12 | JAK3 | 1.85387465 |
13 | SIK1 | 1.83500970 |
14 | MAP3K14 | 1.77243166 |
15 | SMG1 | 1.77009542 |
16 | FGFR4 | 1.76365632 |
17 | DDR2 | 1.75046476 |
18 | PIM2 | 1.71278111 |
19 | FLT3 | 1.69177244 |
20 | KIT | 1.68536569 |
21 | ZAP70 | 1.61665031 |
22 | JAK1 | 1.59995756 |
23 | EPHB1 | 1.57703172 |
24 | GRK7 | 1.56720691 |
25 | PTK6 | 1.54164707 |
26 | BCKDK | 1.47759480 |
27 | IKBKE | 1.45785049 |
28 | STK10 | 1.45632253 |
29 | MST1R | 1.42121202 |
30 | EEF2K | 1.39972700 |
31 | ICK | 1.39915623 |
32 | MAP2K3 | 1.38691761 |
33 | NEK9 | 1.37835435 |
34 | MAP3K1 | 1.37047606 |
35 | RPS6KA4 | 1.35264775 |
36 | CSF1R | 1.33772550 |
37 | MOS | 1.33738780 |
38 | RIPK1 | 1.33219967 |
39 | LRRK2 | 1.32295805 |
40 | IKBKB | 1.32218353 |
41 | EPHA3 | 1.23451831 |
42 | TTN | 1.22468488 |
43 | IRAK2 | 1.21623037 |
44 | SIK3 | 1.20636864 |
45 | BTK | 1.19380181 |
46 | TGFBR2 | 1.18893754 |
47 | IRAK4 | 1.17356361 |
48 | FGR | 1.12815676 |
49 | TESK1 | 1.11897376 |
50 | CAMK1D | 1.11056552 |
51 | NME2 | 1.11010419 |
52 | CSK | 1.08229632 |
53 | ARAF | 1.06744316 |
54 | MAP3K3 | 1.06002534 |
55 | BMPR2 | 1.05635887 |
56 | GRK6 | 1.05081112 |
57 | CHUK | 1.03943601 |
58 | EPHA2 | 1.02833330 |
59 | TESK2 | 1.00217255 |
60 | PIM1 | 0.96884425 |
61 | MAP3K11 | 0.96211181 |
62 | IRAK1 | 0.95103013 |
63 | SYK | 0.94509312 |
64 | RIPK4 | 0.93788063 |
65 | MAPK11 | 0.91703759 |
66 | TXK | 0.90706951 |
67 | BMX | 0.90000305 |
68 | JAK2 | 0.86869508 |
69 | FGFR3 | 0.84139215 |
70 | TEC | 0.80067107 |
71 | KDR | 0.79704410 |
72 | PRKG2 | 0.79324898 |
73 | HCK | 0.79245272 |
74 | MYLK | 0.79071512 |
75 | MAPK7 | 0.78431069 |
76 | PIK3CA | 0.77727020 |
77 | ITK | 0.77557700 |
78 | FRK | 0.76975187 |
79 | DMPK | 0.74761762 |
80 | PRKD2 | 0.74243463 |
81 | CDK12 | 0.72941666 |
82 | PDGFRA | 0.72138259 |
83 | LCK | 0.71656707 |
84 | LYN | 0.70659892 |
85 | TRPM7 | 0.69544111 |
86 | TAOK2 | 0.69434026 |
87 | SCYL2 | 0.67866554 |
88 | MATK | 0.66716607 |
89 | CDC42BPA | 0.65710262 |
90 | PAK4 | 0.65141398 |
91 | MAP3K8 | 0.64403881 |
92 | PIK3CG | 0.61558772 |
93 | NUAK1 | 0.58236666 |
94 | KSR2 | 0.57101219 |
95 | MAP3K5 | 0.57017260 |
96 | PRKAA2 | 0.56877451 |
97 | PDPK1 | 0.56387671 |
98 | MARK2 | 0.55660667 |
99 | SIK2 | 0.54989856 |
100 | MTOR | 0.54956719 |
101 | MARK3 | 0.53874503 |
102 | TNK2 | 0.53217098 |
103 | MAP3K7 | 0.52971796 |
104 | RPS6KA6 | 0.52913923 |
105 | STK3 | 0.51845405 |
106 | TAOK1 | 0.51272486 |
107 | STK4 | 0.51121526 |
108 | ABL2 | 0.50528182 |
109 | CDK6 | 0.50006499 |
110 | CAMK1G | 0.49214315 |
111 | LATS2 | 0.48218044 |
112 | PAK2 | 0.47501720 |
113 | MAP3K13 | 0.47220593 |
114 | PTK2 | 0.46420449 |
115 | HIPK2 | 0.46215899 |
116 | MAPK4 | 0.45822731 |
117 | MAPKAPK2 | 0.45216909 |
118 | MET | 0.44998092 |
119 | RPS6KL1 | 0.44644439 |
120 | RPS6KC1 | 0.44644439 |
121 | DAPK3 | 0.43950482 |
122 | PDGFRB | 0.42580512 |
123 | EGFR | 0.41825930 |
124 | ILK | 0.41814963 |
125 | STK24 | 0.41484378 |
126 | PDK1 | 0.40863369 |
127 | RPS6KA2 | 0.40338365 |
128 | CLK1 | 0.39940350 |
129 | MAP2K6 | 0.37460353 |
130 | CDK4 | 0.35066720 |
131 | MAPK12 | 0.34892629 |
132 | FES | 0.31467890 |
133 | MELK | 0.29843113 |
134 | BRAF | 0.28204126 |
135 | MAP3K9 | 0.28007683 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.42685472 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.16208561 |
3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.09405524 |
4 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.04397567 |
5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.02852077 |
6 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.02383848 |
7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.00985084 |
8 | Asthma_Homo sapiens_hsa05310 | 1.99673938 |
9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.95211575 |
10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.91977296 |
11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.81513531 |
12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.79970392 |
13 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.77169806 |
14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.72749577 |
15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.68143238 |
16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.65606613 |
17 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.58531428 |
18 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.58049432 |
19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.57689439 |
20 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.56237372 |
21 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.54923827 |
22 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.51963629 |
23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.46886418 |
24 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.42736144 |
25 | Legionellosis_Homo sapiens_hsa05134 | 1.40547001 |
26 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.38090313 |
27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.37225356 |
28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.36502829 |
29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.35657802 |
30 | Bladder cancer_Homo sapiens_hsa05219 | 1.34263825 |
31 | Lysosome_Homo sapiens_hsa04142 | 1.34146334 |
32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.30447633 |
33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28450284 |
34 | Prion diseases_Homo sapiens_hsa05020 | 1.27667917 |
35 | Sulfur relay system_Homo sapiens_hsa04122 | 1.25863289 |
36 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.24227605 |
37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.21960328 |
38 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.21307070 |
39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.20001981 |
40 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.18261000 |
41 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.17894642 |
42 | Measles_Homo sapiens_hsa05162 | 1.16697522 |
43 | Tuberculosis_Homo sapiens_hsa05152 | 1.16046593 |
44 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.15706177 |
45 | Malaria_Homo sapiens_hsa05144 | 1.15199420 |
46 | Galactose metabolism_Homo sapiens_hsa00052 | 1.14850838 |
47 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.14293904 |
48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.13718384 |
49 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.12083278 |
50 | * Pertussis_Homo sapiens_hsa05133 | 1.11388861 |
51 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.09961612 |
52 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.07933029 |
53 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.06811508 |
54 | Phagosome_Homo sapiens_hsa04145 | 1.05070643 |
55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.04859309 |
56 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.00742204 |
57 | Peroxisome_Homo sapiens_hsa04146 | 1.00698710 |
58 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.99594555 |
59 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.98710574 |
60 | Histidine metabolism_Homo sapiens_hsa00340 | 0.97991404 |
61 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.97733472 |
62 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.97529522 |
63 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.95943075 |
64 | Lysine degradation_Homo sapiens_hsa00310 | 0.95479827 |
65 | Apoptosis_Homo sapiens_hsa04210 | 0.95450512 |
66 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.95357915 |
67 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.95313014 |
68 | * Influenza A_Homo sapiens_hsa05164 | 0.94402805 |
69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.93673093 |
70 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.92954459 |
71 | Insulin resistance_Homo sapiens_hsa04931 | 0.92839100 |
72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.89817821 |
73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89276782 |
74 | Carbon metabolism_Homo sapiens_hsa01200 | 0.87644450 |
75 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.87231007 |
76 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87140678 |
77 | ABC transporters_Homo sapiens_hsa02010 | 0.85182397 |
78 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.83080956 |
79 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.82449743 |
80 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.82078571 |
81 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.81212363 |
82 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.80126931 |
83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.79604340 |
84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.79167677 |
85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.78132230 |
86 | Viral myocarditis_Homo sapiens_hsa05416 | 0.77697602 |
87 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77647938 |
88 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.76313573 |
89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76011505 |
90 | * Herpes simplex infection_Homo sapiens_hsa05168 | 0.75396510 |
91 | Bile secretion_Homo sapiens_hsa04976 | 0.75109991 |
92 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73936860 |
93 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.72116907 |
94 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.72011717 |
95 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.69512947 |
96 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.68251425 |
97 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.67833424 |
98 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.67550094 |
99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66800979 |
100 | HTLV-I infection_Homo sapiens_hsa05166 | 0.66207099 |
101 | Allograft rejection_Homo sapiens_hsa05330 | 0.66015695 |
102 | Shigellosis_Homo sapiens_hsa05131 | 0.65526120 |
103 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.65502236 |
104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.64720844 |
105 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.64459668 |
106 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.64273772 |
107 | Amoebiasis_Homo sapiens_hsa05146 | 0.63251037 |
108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63120213 |
109 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.62868789 |
110 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.62582762 |
111 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.61820850 |
112 | * Hepatitis B_Homo sapiens_hsa05161 | 0.61609124 |
113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59859134 |
114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59289632 |
115 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.58567067 |
116 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58171618 |
117 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57647495 |
118 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.56922469 |
119 | Salmonella infection_Homo sapiens_hsa05132 | 0.56389392 |
120 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56221602 |
121 | * Hepatitis C_Homo sapiens_hsa05160 | 0.55943706 |
122 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.55069736 |
123 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54416082 |
124 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53627106 |
125 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.53572392 |
126 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52667508 |
127 | Endocytosis_Homo sapiens_hsa04144 | 0.51446755 |
128 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.50514888 |
129 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.49941617 |
130 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.46085147 |
131 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44141733 |
132 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41405576 |
133 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40742903 |
134 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37165307 |
135 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.35019057 |
136 | Platelet activation_Homo sapiens_hsa04611 | 0.34744570 |
137 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.34615187 |
138 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.33794416 |
139 | Prostate cancer_Homo sapiens_hsa05215 | 0.33333328 |
140 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.33217339 |
141 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.33030396 |
142 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31977242 |
143 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.30593106 |
144 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.28695583 |
145 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.26712643 |
146 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.26395597 |